Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C7H14N2O6S |
| Molecular Weight | 254.261 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CCC(=O)NCCS(O)(=O)=O)C(O)=O
InChI
InChIKey=WGXUDTHMEITUBO-YFKPBYRVSA-N
InChI=1S/C7H14N2O6S/c8-5(7(11)12)1-2-6(10)9-3-4-16(13,14)15/h5H,1-4,8H2,(H,9,10)(H,11,12)(H,13,14,15)/t5-/m0/s1
| Molecular Formula | C7H14N2O6S |
| Molecular Weight | 254.261 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Glutaurine is formed from the amino group of taurine with the gamma-carboxy group of L-glutamic acid. It was originally discovered in the parathyroid. Evidence has been found suggesting that glutaurine plays a role in peripheral thyroid hormonal regulation. Glutaurine increases triiodothyronine (T3) levels, but does not alter thyroxine (T4) levels. Glutaurine was also shown to prevent electroconvulsive shock-induced amnesia by counteracting the shock effect on the memory consolidation phase. Other roles that have been suggested for glutaurine include roles as a mouse metabolite, a mammalian metabolite, a human metabolite, an anticonvulsant, an anxiolytic drug and a hormone.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15838590 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:06 GMT 2025
by
admin
on
Mon Mar 31 18:33:06 GMT 2025
|
| Record UNII |
B5T2Z06Y9N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C73539
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20205030
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
GLUTAURINE
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
3966
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
27694
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
C020903
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
68759
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
56488-60-9
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
B5T2Z06Y9N
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
100000084229
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
C72802
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106758
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY | |||
|
SUB07944MIG
Created by
admin on Mon Mar 31 18:33:06 GMT 2025 , Edited by admin on Mon Mar 31 18:33:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |